When.com Web Search

  1. Ads

    related to: newest treatment for breast cancer

Search results

  1. Results From The WOW.Com Content Network
  2. Breast cancer management - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer_management

    Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.

  3. Breast Cancer Research Foundation - Wikipedia

    en.wikipedia.org/wiki/Breast_Cancer_Research...

    BCRF has funded basic research on genetic susceptibility to breast cancer, breast cancer stem cells, trastuzumab (Herceptin), anti-angiogenesis treatment with bevacizumab (Avastin), MRI imaging, aromatase inhibitors, tamoxifen; and also clinical trials of new treatments with the Translational Breast Cancer Research Consortium.

  4. Exemestane - Wikipedia

    en.wikipedia.org/wiki/Exemestane

    Exemestane, sold under the brand name Aromasin among others, is a medication used to treat breast cancer. It is a member of the class of antiestrogens known as aromatase inhibitors. Some breast cancers require estrogen to grow. Those cancers have estrogen receptors (ERs), and are called ER-positive. They may also be called estrogen-responsive ...

  5. CDK inhibitor - Wikipedia

    en.wikipedia.org/wiki/CDK_inhibitor

    Another remaining question surrounding CDK inhibitors as a therapy is if certain cancers will evade or be resistant to treatment. One study showed that 20% of the patients being treated for metastatic ER+ HER2-breast cancer did not respond at all to treatment with a CDK4/6 inhibitor due to preexisting mutations allowing the cancer cells to continue proliferating despite treatment with the drug ...

  6. Palbociclib - Wikipedia

    en.wikipedia.org/wiki/Palbociclib

    Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. [5] [6] Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy. [7]

  7. Breast cancer - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer

    This is an accepted version of this page This is the latest accepted revision, reviewed on 29 January 2025. Cancer that originates in mammary glands Medical condition Breast cancer An illustration of breast cancer Specialty Surgical Oncology Symptoms A lump in a breast, a change in breast shape, dimpling of the skin, fluid from the nipple, a newly inverted nipple, a red scaly patch of skin on ...

  1. Ads

    related to: newest treatment for breast cancer